Among PAKs, PAK1, PAK2, and PAK4 exhibit a higher expression level in most cancer types; PAK1 and PAK4 are the most studied and better characterized, yet PAK2 has the highest alteration frequency among all PAKs, especially in lung cancer [173]. Here, PAK1 is linked to lung carcinoma.